Wagener P, Münch H, Junker D
Abteilung Erkrankungen der Bewegungsorgane und des Stoffwechsels.
Z Rheumatol. 1988 Jul-Aug;47(4):201-4.
Yttrium-90 radiosynoviorthesis of the knee joint in rheumatic inflammatory diseases shows favourable results. Because of the supposed exposure of the patients gonads, Yttrium synoviorthesis has rarely been performed in patients below the age of 40. Scintigraphic studies in 20 patients with rheumatoid arthritis showed no significant leakage of the radionuclide from the knee joint. Gamma camera measurements both phantom and in vivo in the regions of ovary and testes revealed a local dose of 1.05 microGy/MBq (3.9 mrd/mCi) or 1.1 microGy/MBq (4.1 mrd/mCi) of the injected radioactivity. Calculation of the maximum possible load of the gonads, supposing even total leakage of the injected 90-Yttrium from the knee joint, yielded a maximum possible dose of 6 mGy (600 mrd). We conclude from these studies and calculations that Yttrium-90 synoviorthesis of the knee joint can safely be carried out in patients below the age of 40.
钇-90放射性滑膜切除术治疗风湿性炎症性疾病的膝关节显示出良好的效果。由于考虑到患者性腺可能受到照射,40岁以下患者很少进行钇滑膜切除术。对20例类风湿性关节炎患者的闪烁扫描研究表明,放射性核素没有从膝关节显著泄漏。γ相机在体模以及卵巢和睾丸区域的体内测量显示,注入放射性活度的局部剂量为1.05微戈瑞/兆贝可(3.9毫雷姆/毫居里)或1.1微戈瑞/兆贝可(4.1毫雷姆/毫居里)。假设注入的钇-90从膝关节完全泄漏,计算性腺的最大可能负荷,得出最大可能剂量为6毫戈瑞(600毫雷姆)。我们从这些研究和计算得出结论,40岁以下患者可以安全地进行钇-90膝关节滑膜切除术。